Advanced search
1 file | 1.26 MB Add to list

Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period

(2015) BMJ OPEN. 5(6).
Author
Organization
Abstract
Introduction: Soil-transmitted helminth infections are endemic in 114 countries worldwide, and cause the highest burden of disease among all neglected tropical diseases. The WHO includes women of reproductive age as a high-risk group for infection. The primary consequence of infection in this population is anaemia. During lactation, anaemia may contribute to reduced quality and quantity of milk, decreasing the duration of exclusive breastfeeding and lowering the age at weaning. To date, no study has investigated the effects of maternal postpartum deworming on infant or maternal health outcomes. Methods and analysis: A single-centre, parallel, double-blind, randomised, placebo-controlled trial will be carried out in Iquitos, Peru, to assess the effectiveness of integrating single-dose 400 mg albendazole into routine maternal postpartum care. A total of 1010 mother-infant pairs will be randomised to either the intervention or control arm, following inhospital delivery and prior to discharge. Participants will be visited in their homes at 1, 6, 12 and 24 months following delivery for outcome ascertainment. The primary outcome is infant mean weight gain between birth and 6 months of age. Secondary outcomes include other infant growth indicators and morbidity, maternal soil-transmitted helminth infection and intensity, anaemia, fatigue, and breastfeeding practices. All statistical analyses will be performed on an intention-to-treat basis. Ethics and dissemination: Research ethics board approval has been obtained from the McGill University Health Centre (Canada), the Asociacion Civil Impacta Salud y Educacion (Peru) and the Instituto Nacional de Salud (Peru). A data safety and monitoring committee is in place to oversee study progression and evaluate adverse events. The results of the analyses will be published in peer-reviewed journals, and presented at national and international conferences.
Keywords
IMPACT, CONSEQUENCES, HEALTH, SUPPLEMENTATION, BREAST-FED INFANTS, CHILD UNDERNUTRITION, TERM INFANTS, PREGNANCY, MILK, ANEMIA

Downloads

  • BMJ Open-2015-Mofid-.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 1.26 MB

Citation

Please use this url to cite or link to this publication:

MLA
Mofid, Laysa S., et al. “Maternal Deworming Research Study (MADRES) Protocol: A Double-Blind, Placebo-Controlled Randomised Trial to Determine the Effectiveness of Deworming in the Immediate Postpartum Period.” BMJ OPEN, vol. 5, no. 6, 2015, doi:10.1136/bmjopen-2015-008560.
APA
Mofid, L. S., Casapía, M., Montresor, A., Rahme, E., Fraser, W. D., Marquis, G. S., … Gyorkos, T. W. (2015). Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period. BMJ OPEN, 5(6). https://doi.org/10.1136/bmjopen-2015-008560
Chicago author-date
Mofid, Laysa S, Martín Casapía, Antonio Montresor, Elham Rahme, William D Fraser, Grace S Marquis, Jozef Vercruysse, Lindsay H Allen, and Theresa W Gyorkos. 2015. “Maternal Deworming Research Study (MADRES) Protocol: A Double-Blind, Placebo-Controlled Randomised Trial to Determine the Effectiveness of Deworming in the Immediate Postpartum Period.” BMJ OPEN 5 (6). https://doi.org/10.1136/bmjopen-2015-008560.
Chicago author-date (all authors)
Mofid, Laysa S, Martín Casapía, Antonio Montresor, Elham Rahme, William D Fraser, Grace S Marquis, Jozef Vercruysse, Lindsay H Allen, and Theresa W Gyorkos. 2015. “Maternal Deworming Research Study (MADRES) Protocol: A Double-Blind, Placebo-Controlled Randomised Trial to Determine the Effectiveness of Deworming in the Immediate Postpartum Period.” BMJ OPEN 5 (6). doi:10.1136/bmjopen-2015-008560.
Vancouver
1.
Mofid LS, Casapía M, Montresor A, Rahme E, Fraser WD, Marquis GS, et al. Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period. BMJ OPEN. 2015;5(6).
IEEE
[1]
L. S. Mofid et al., “Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period,” BMJ OPEN, vol. 5, no. 6, 2015.
@article{7093913,
  abstract     = {{Introduction: Soil-transmitted helminth infections are endemic in 114 countries worldwide, and cause the highest burden of disease among all neglected tropical diseases. The WHO includes women of reproductive age as a high-risk group for infection. The primary consequence of infection in this population is anaemia. During lactation, anaemia may contribute to reduced quality and quantity of milk, decreasing the duration of exclusive breastfeeding and lowering the age at weaning. To date, no study has investigated the effects of maternal postpartum deworming on infant or maternal health outcomes. 
Methods and analysis: A single-centre, parallel, double-blind, randomised, placebo-controlled trial will be carried out in Iquitos, Peru, to assess the effectiveness of integrating single-dose 400 mg albendazole into routine maternal postpartum care. A total of 1010 mother-infant pairs will be randomised to either the intervention or control arm, following inhospital delivery and prior to discharge. Participants will be visited in their homes at 1, 6, 12 and 24 months following delivery for outcome ascertainment. The primary outcome is infant mean weight gain between birth and 6 months of age. Secondary outcomes include other infant growth indicators and morbidity, maternal soil-transmitted helminth infection and intensity, anaemia, fatigue, and breastfeeding practices. All statistical analyses will be performed on an intention-to-treat basis. 
Ethics and dissemination: Research ethics board approval has been obtained from the McGill University Health Centre (Canada), the Asociacion Civil Impacta Salud y Educacion (Peru) and the Instituto Nacional de Salud (Peru). A data safety and monitoring committee is in place to oversee study progression and evaluate adverse events. The results of the analyses will be published in peer-reviewed journals, and presented at national and international conferences.}},
  articleno    = {{e008560}},
  author       = {{Mofid, Laysa S and Casapía, Martín and Montresor, Antonio and Rahme, Elham and Fraser, William D and Marquis, Grace S and Vercruysse, Jozef and Allen, Lindsay H and Gyorkos, Theresa W}},
  issn         = {{2044-6055}},
  journal      = {{BMJ OPEN}},
  keywords     = {{IMPACT,CONSEQUENCES,HEALTH,SUPPLEMENTATION,BREAST-FED INFANTS,CHILD UNDERNUTRITION,TERM INFANTS,PREGNANCY,MILK,ANEMIA}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{9}},
  title        = {{Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period}},
  url          = {{http://doi.org/10.1136/bmjopen-2015-008560}},
  volume       = {{5}},
  year         = {{2015}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: